Table 3 Baseline (T0) and follow-up (T1) means and standard deviation (SD) in intervention and control group, difference between T1 and T0 within groups, difference in differences of intervention and control group with corresponding 95% confidence intervals (95%-CI) of self-rated symptom-related and psychosocial parameters in intention-to-treat analysis.
Parameter name (range) | Intervention baseline (T0) Mean ± SD | Control baseline (T0) Mean ± SD | Intervention follow-up (T1) Mean ± SD | Control follow-up (T1) Mean ± SD | Difference intervention T1-T0 | Difference control T1-T0 | Difference in differences (DID) T1-T0 [95%-CI] | Difference in differences (DID) T1-T0 [95%-CI} standardized§ | Direction of DID$ |
---|---|---|---|---|---|---|---|---|---|
N | 26 | 28 | 26 | 28 | |||||
Current health status (1–5) | 2.88 ± 0.77 | 2.86 ± 0.76 | 2.54 ± 0.81 | 2.78 ± 0.89 | − 0.35 | − 0.08 | − 0.27 [− 0.89,0.35] | − 0.35 [− 1.18,0.47] | + |
Quality of life (1–4) | 3.50 ± 0.58 | 3.50 ± 0.51 | 3.62 ± 0.57 | 3.59 ± 0.57 | 0.12 | 0.09 | 0.02 [− 0.41,0.45] | 0.03 [− 1.18,0.47] | + |
Satisfaction in general (1–4) | 3.23 ± 0.59 | 3.21 ± 0.57 | 3.04 ± 0.72 | 3.00 ± 0.68 | − 0.19 | − 0.21 | 0.02 [− 0.47,0.51] | 0.04 [− 0.82,0.90] | − |
Satisfaction with health (1–4) | 3.08 ± 0.63 | 3.04 ± 0.51 | 3.12 ± 0.59 | 3.23 ± 0.71 | 0.04 | 0.20 | − 0.16 [− 0.63,0.31] | − 0.28 [− 1.11,0.56] | − |
Movement competence* (1–4) | 2.90 ± 0.67 | 2.62 ± 0.87 | 3.07 ± 0.62 | 2.68 ± 0.74 | 0.17 | 0.06 | 0.12 [− 0.45,0.69] | 0.15 [− 0.57,0.87] | + |
Control competence* (1–4) | 2.62 ± 0.70 | 2.40 ± 0.62 | 2.87 ± 0.62 | 2.50 ± 0.60 | 0.25 | 0.10 | 0.15 [− 0.34,0.64] | 0.23 [− 0.52,0.97] | + |
Self-regulation competence* (1–4) | 2.81 ± 0.61 | 2.80 ± 0.63 | 2.91 ± 0.60 | 2.65 ± 0.67 | 0.11 | − 0.16 | 0.26 [− 0.23,0.75] | 0.43 [− 0.37,1.22] | + |
Symptoms of depression (0–45) | 9.64 ± 6.39 | 10.14 ± 7.95 | 8.43 ± 7.32 | 10.89 ± 7.18 | − 1.21 | 0.75 | − 1.96 [− 7.55,3.63] | − 0.27 [− 1.05,0.51] | + |
Fatigue# (0–10) | 4.81 ± 1.94 | 4.70 ± 2.05 | 3.76 ± 2.02 | 4.40 ± 2.16 | − 1.04 | − 0.30 | − 0.75 [− 2.53,1.03] | − 0.38 [− 1.28,0.52] | + |
Concentration disorders# (0–10) | 4.41 ± 2.12 | 4.04 ± 2.34 | 3.53 ± 1.92 | 3.86 ± 2.38 | − 0.88 | − 0.18 | − 0.70 [− 2.76,1.36] | − 0.31 [− 1.24,0.61] | + |
Difficulty breathing# (0–10) | 4.40 ± 1.96 | 4.41 ± 2.29 | 3.33 ± 1.87 | 3.83 ± 1.92 | − 1.07 | − 0.58 | − 0.49 [− 2.58,1.60] | − 0.23 [− 1.22,0.76] | + |
Headache# (0–10) | 4.57 ± 2.82 | 4.10 ± 2.51 | 2.00 ± 1.26 | 4.07 ± 2.69 | − 2.57 | − 0.03 | − 2.54 [− 6.05,0.98] | − 0.99 [− 2.36,0.38] | + |
Current physical performance (0–10) | 5.46 ± 1.77 | 5.39 ± 1.89 | 6.77 ± 1.66 | 5.50 ± 1.82 | 1.31 | 0.11 | 1.20 [− 0.17,2.57] | 0.66 [− 0.09,1.41] | + |
Sleep quality (1–3) | 2.12 ± 0.59 | 2.30 ± 0.54 | 2.04 ± 0.60 | 2.19 ± 0.63 | − 0.08 | − 0.10 | 0.03 [− 0.43,0.48] | 0.05 [− 0.76, 0.86] | − |